Blackstone Life Sciences β Full Portfolio
10 tracked investments Β· listed companies and verified rows first
Alnylam is a biopharmaceutical company that supports investigator-initiated studies in therapeutic areas including transthyretin-mediated amyloidosis, acute hepatic porphyria, and primary hyperoxaluria for medical researchers and healthcare professionals.
BiotechDigital HealthMedical Devices
John Maraganore(Founder)inDr. Yvonne Greenstreet(Chief Executive Officer)inJeffrey V. Poulton(Executive Vice President and Chief Financial Officer)Bryan A. Supran(Executive Vice President, Chief Legal Officer and Secretary)inPushkal Garg(Executive Vice President and Chief Research and Development Officer)inTolga Tanguler(Chief Commercial Officer)in
Co-investorsARCH Venture PartnersAtlas VentureCardinal PartnersInvivo Capital Partners
Apogee Therapeutics develops engineered antibody therapies to treat inflammatory and immune diseases with reduced injection frequency compared to existing treatments.
BiotechHealthtechMedical Devices
Michael Henderson(Chief Executive Officer and Director)in
Co-investorsAccess BiotechnologyRA CapitalPerceptive Xontogeny VentureRTW Investments L.P.Venrock Healthcare Capital Partners
AvenCell Therapeutics develops next-generation cell therapies for hard-to-treat cancers, including solid tumors, combining switchable universal CAR-T technology with a CRISPR/Cas9-based allogeneic platform.
BiotechLongevityMedical Devices
Andrew Schiermeier(Chief Executive Officer)in
Co-investorsNovo HoldingsEight Roads VenturesF-Prime CapitalNYBC Ventures
Anagram provides insurance administration and revenue cycle management software and billing services for eye care practices, covering eligibility and benefits verification, claim submission and scrubbing, denial management, and payment reconciliation across both vision and medical insurance.
HealthtechInsurTechSaaS
Co-investorsFundersClubHealthy VenturesKEC VenturesKickstartNextView VenturesWaterline Ventures
Anagram builds software to help eye care providers manage vision insurance, lab ordering, and administrative workflows so they can deliver better patient care affordably.
Enterprise SoftwareHealthtechInsurTechSaaS
Austin Winfield(Founder)in
Co-investorsGreatPoint VenturesHealthy VenturesManchesterStory Group, LLCKEC VenturesKickstartNextView Ventures+1 more
Anagram describes itself as an institution focused on crypto and the "ownership economy," offering staking services and deploying human and financial capital in the space.
Crypto & Web3
Austin Winfield(Founder)in
Co-investorsMarin Digital VenturesHealthy VenturesKEC VenturesKickstartNextView VenturesWaterline Ventures
Revore builds return and collection systems for reusable packaging and other returnable items, deployed at indoor sites such as offices, airports, universities, hospitals, pharmacies, retail chains, quick-service restaurants, and event arenas.
Circular EconomyCleantechHardware
Co-investorsHeadlineKickstart InnovationBONDBullpen Capital
A pharmaceutical company that develops medicines and vaccines, with research pipelines and clinical trials aimed at new treatments.
BiotechHealthtech
Co-investorsHighlight CapitalAmgen VenturesBlackRockClarus VenturesFrazier Healthcare PartnersGreenspring Associates+4 more
Moderna develops mRNA-based medicines for infectious and serious diseases using its proprietary mRNA platform and design technology.
BiotechDeep TechMedical DevicesCambridge, US
Robert Langer(Director)Noubar Afeyan, Ph.D.(Co-founder and Chairman, Moderna; CEO, Flagship Pioneering)Lorence Kim(Executive Officer)inJames R. Kasinger(Executive Officer)inStephen Hoge(Executive Officer)in
BoardStephane Bancel(Chief Executive Officer)in
Co-investorsAglae VenturesFlagship PioneeringFPVKhosla VenturesPremji InvestRA Capital
Other
Tracked investments with no reachable website or further public details β typically companies that wound down, renamed, or were absorbed.
Anthos Therapeutics, Inc.
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.